SABSW

SAB Biotherapeutics, Inc. SABSW

SABSW
SAB Biotherapeutics, Inc. VINC
Vincerx Pharma, Inc. BACK
IMAC Holdings, Inc. BCTXW
BriaCell Therapeutics Corp. SYRS
Syros Pharmaceuticals, Inc. OCEA
Ocean Biomedical, Inc. NUWE
Nuwellis, Inc. REVB
Revelation Biosciences, Inc. VRPX
Virpax Pharmaceuticals, Inc. KTTA
Pasithea Therapeutics Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SABSW VINC BACK BCTXW SYRS OCEA NUWE REVB VRPX KTTA
6M 8.65 % -88.73 % 52.89 % -9.81 % -98.51 % -97.59 % -91.24 % -86.04 % -91.80 % -47.03 %
YTD -53.39 % -99.34 % -94.58 % -79.82 % -99.83 % -99.83 % -93.17 % -95.91 % -99.78 % -75.05 %
1Y -38.90 % -99.59 % -94.79 % -80.76 % -99.98 % -99.90 % -94.50 % -96.84 % -99.86 % -81.68 %
3Y -61.72 % -99.87 % -99.27 % -98.10 % -99.99 % -99.99 % -99.99 % -99.99 % -99.99 % -96.71 %
5Y -98.07 % -99.99 % -99.69 % -92.28 % -100.00 % -99.99 % -100.00 % -100.00 % -100.00 % -98.97 %
10Y -98.07 % -99.98 % -99.94 % -92.28 % -100.00 % -99.99 % -100.00 % -100.00 % -100.00 % -98.97 %
From the beginning -98.07 % -99.98 % -99.94 % -92.28 % -100.00 % -99.99 % -100.00 % -100.00 % -100.00 % -98.97 %

Dividend